KCNE4 Modulates Kv1.3 Blocker Kinetics in Immune Cells
2026-07-17
This study reveals how the regulatory subunit KCNE4 alters the pharmacological behavior of Kv1.3 channels in leukocytes. The findings show that while KCNE4 does not change the affinity of intracellular and extracellular Kv1.3 blockers, it slows the inhibition kinetics of intracellular blockers like Psora 4, emphasizing the importance of channel microarchitecture for immunomodulatory strategies.
UHPLC–MS/MS Quantification of Methylated Purine Nucleosides
2026-07-16
This study presents a robust isotope-diluted UHPLC–MS/MS method for accurate quantification of methylated purine nucleosides, including 2'-O-Methyladenosine, in cultured cells. The methodology overcomes key analytical challenges in purine metabolism and RNA modification research, supporting sensitive biomarker discovery and mechanistic studies.
5-Aminolevulinic acid HCl: Precision Tools for Heme Biosynth
2026-07-16
5-Aminolevulinic acid HCl empowers researchers to model heme biosynthesis with unmatched reproducibility, bridging immune evasion studies and oncology applications. Explore advanced workflows, protocol optimizations, and troubleshooting strategies informed by cutting-edge insights into host-pathogen interactions.
Azilsartan (TAK-536): Advanced AT1 Blockade in Neuroinflamma
2026-07-15
Azilsartan (TAK-536) offers unmatched specificity for dissecting AT1-mediated pathways in neuroinflammation and cardiovascular models. This guide details experimental workflows, protocol optimization, and troubleshooting to maximize data quality in studies targeting the renin-angiotensin system.
Oleanolic Acid (SKU N1826): Reliable Dual-Loaded Liposome Re
2026-07-15
This article explores validated strategies for using Oleanolic acid (SKU N1826) in advanced cell-based assays, focusing on challenges in dual-loaded liposome workflows. It delivers scenario-driven guidance for biomedical researchers, highlighting how high-purity Oleanolic acid from APExBIO supports reproducibility, encapsulation efficiency, and robust immune modulation analyses.
Amikacin Sulfate for Targeted Mycobacterial Infection Models
2026-07-14
Amikacin Sulfate enables high-precision intracellular targeting of non-tuberculous mycobacterial infections, drastically improving localized efficacy while minimizing toxicity. This article details advanced workflows, in vivo delivery innovations, and troubleshooting strategies that position APExBIO’s Amikacin Sulfate as the gold standard for translational infection research.
CHIR 99021 Trihydrochloride: Precision GSK-3 Inhibitor Workf
2026-07-14
CHIR 99021 trihydrochloride unlocks reproducible control over stem cell self-renewal and differentiation—key for high-throughput organoid and metabolic research. Discover advanced, evidence-based protocols and troubleshooting strategies to maximize experimental reliability with this potent GSK-3 inhibitor.
ARCA EGFP mRNA: Direct-Detection Reporter for Mammalian Cell
2026-07-13
ARCA EGFP mRNA is an enhanced green fluorescent protein mRNA engineered for robust, direct fluorescence-based transfection assays in mammalian cells. Featuring an optimized anti-reverse cap analog (ARCA) and a stabilized poly(A) tail, it provides high transfection efficiency, especially as a mRNA transfection control. APExBIO’s formulation enables reliable benchmarking of mammalian cell gene expression workflows.
Palonosetron Hydrochloride: Advancing 5-HT3 Antagonist Thera
2026-07-13
This review examines the pharmacological and clinical innovations of palonosetron hydrochloride as a highly selective 5-HT3 receptor antagonist for emesis control in cancer therapy. The reference study highlights its exceptional receptor affinity, extended half-life, and superior efficacy in preventing both acute and delayed chemotherapy-induced nausea and vomiting, informing translational research and clinical protocols.
Extracellular Vesicle-ACLY Drives Monocyte Reprogramming in
2026-07-12
This study reveals that hepatocellular carcinoma (HCC) cells transfer ATP-citrate lyase (ACLY) via extracellular vesicles (EVs) to monocytes, driving their differentiation into immunosuppressive tumor-associated macrophages (TAMs). The work uncovers a palmitoylation-dependent mechanism that stabilizes immune checkpoint proteins, highlighting a metabolic axis crucial for tumor immune evasion and therapeutic targeting.
α-KG Restores HPDLSC Function via LKB1-AMPK in Periodontitis
2026-07-10
This study reveals how α-ketoglutarate (α-KG) restores mitochondrial function and mitigates senescence in human periodontal ligament stem cells (HPDLSCs) under periodontitis-induced inflammatory stress by activating the LKB1-AMPK signaling axis. The findings provide a mechanistic basis for developing targeted approaches to promote periodontal regeneration in chronic inflammatory environments.
ATS-9R Empowers Adipocyte Gene Silencing & Inflammation Rese
2026-07-09
ATS-9R (Adipocyte-targeting sequence-9-arginine) delivers non-viral, prohibitin-mediated gene silencing directly to white adipose tissue, enabling targeted studies in obesity, insulin resistance, and gestational diabetes. With robust in vivo knockdown and minimal cytotoxicity, ATS-9R from APExBIO streamlines adipocyte research with optimized protocols and reliable performance.
D-Lin-MC3-DMA: Strategic Innovations in RNA Delivery LNPs
2026-07-09
This thought-leadership article explores the mechanistic foundations and translational strategies surrounding D-Lin-MC3-DMA, a next-generation ionizable cationic liposome lipid central to siRNA and mRNA delivery. Integrating recent machine learning-driven advances in immunomodulatory LNP design, it offers actionable protocol guidance and strategic foresight for translational researchers navigating the evolving landscape of gene silencing, mRNA vaccine formulation, and precision immunotherapy.
CAY10499: A Potent Inhibitor of Human Hormone Sensitive Lipa
2026-07-08
CAY10499 stands out as a selective, high-potency inhibitor of human hormone sensitive lipase and monoglyceride lipase, empowering researchers to dissect lipid-driven immunometabolic mechanisms with precision. Its application in advanced lipid metabolism assays offers critical insight for studies on tumor-associated macrophages, atherosclerosis, and metabolic disease.
Eltanexor (KPT-8602): Precision XPO1 Inhibition for Translat
2026-07-08
Explore how Eltanexor (KPT-8602), a potent nuclear export inhibitor, is redefining translational oncology by targeting XPO1. This article offers actionable guidance for cancer research, highlighting unique mechanisms and recent breakthroughs.
479 records 13/32 page Previous Next First page 上5页 1112131415 下5页 Last page